PERSPECTA

News from every angle

← Back to headlines

FDA-Approved Drug Manufacturing Shifts to Europe Amid Tariffs

Due to the impact of tariffs, deals for FDA-approved drug manufacturing are increasingly relocating to Europe, indicating a significant shift in the global pharmaceutical supply chain.

7 Apr, 13:41 — 7 Apr, 13:41
PostShare

Sources

Showing 1 of 1 sources
YahooMostly Factual13h ago

In the face of tariffs, FDA-approved drug manufacturing deals are shifting to Europe

Read full article →

Related Stories

PNP Vows to Cut Funds from P9.75M Illegal Diesel Scheme in Navotas

just now

Global Oil Prices Remain High Amid Persistent Middle East Tensions

just now

Two Suspects Charged in Quezon City Diesel Pilferage Incident

just now

Philippines to Begin Service Contracting for Public Utility Vehicles

just now